{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-064144","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2025-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.982055+00:00","generated_at":"2026-05-18T13:04:58.711394+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Nasdaq grants Entero Therapeutics extension to Oct 8, 2025 to meet minimum equity requirement","bullets":["Company received Nasdaq extension letter on June 25, 2025; deadline to regain compliance is October 8, 2025.","Must meet Nasdaq Rule 5550(b)(1) minimum stockholders' equity of $2.5 million.","As of Dec 31, 2024, stockholders' equity was negative $3.88 million, triggering the deficiency.","Failure to regain compliance may result in delisting, but appeal to a Nasdaq Hearing Panel is permitted.","No assurance that compliance will be achieved or listing maintained."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-064144","json":"https://secwatch.observer/filing/0001104659-25-064144.json","markdown":"https://secwatch.observer/filing/0001104659-25-064144.md","text":"https://secwatch.observer/filing/0001104659-25-064144.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925064144/0001104659-25-064144-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925064144/tm2519504d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T13:04:58.711394+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}